1. Home
  2. HUMAW vs PRU Comparison

HUMAW vs PRU Comparison

Compare HUMAW & PRU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMAW
  • PRU
  • Stock Information
  • Founded
  • HUMAW 2004
  • PRU 1875
  • Country
  • HUMAW United States
  • PRU United States
  • Employees
  • HUMAW 220
  • PRU N/A
  • Industry
  • HUMAW Biotechnology: Pharmaceutical Preparations
  • PRU Life Insurance
  • Sector
  • HUMAW Health Care
  • PRU Finance
  • Exchange
  • HUMAW Nasdaq
  • PRU Nasdaq
  • Market Cap
  • HUMAW N/A
  • PRU N/A
  • IPO Year
  • HUMAW N/A
  • PRU N/A
  • Fundamental
  • Price
  • HUMAW $0.41
  • PRU $107.11
  • Analyst Decision
  • HUMAW
  • PRU Hold
  • Analyst Count
  • HUMAW 0
  • PRU 13
  • Target Price
  • HUMAW N/A
  • PRU $120.15
  • AVG Volume (30 Days)
  • HUMAW 14.2K
  • PRU 1.5M
  • Earning Date
  • HUMAW 03-21-2025
  • PRU 07-31-2025
  • Dividend Yield
  • HUMAW N/A
  • PRU 5.02%
  • EPS Growth
  • HUMAW N/A
  • PRU 7.49
  • EPS
  • HUMAW N/A
  • PRU 6.33
  • Revenue
  • HUMAW N/A
  • PRU $60,366,000,000.00
  • Revenue This Year
  • HUMAW N/A
  • PRU N/A
  • Revenue Next Year
  • HUMAW N/A
  • PRU $5.05
  • P/E Ratio
  • HUMAW N/A
  • PRU $16.98
  • Revenue Growth
  • HUMAW N/A
  • PRU N/A
  • 52 Week Low
  • HUMAW $1.18
  • PRU $90.38
  • 52 Week High
  • HUMAW $1.34
  • PRU $130.55
  • Technical
  • Relative Strength Index (RSI)
  • HUMAW N/A
  • PRU 58.05
  • Support Level
  • HUMAW N/A
  • PRU $105.22
  • Resistance Level
  • HUMAW N/A
  • PRU $107.59
  • Average True Range (ATR)
  • HUMAW 0.00
  • PRU 1.70
  • MACD
  • HUMAW 0.00
  • PRU 0.27
  • Stochastic Oscillator
  • HUMAW 0.00
  • PRU 85.10

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: